TSS, a prominent provider of temperature monitoring solutions, is delighted to announce the appointment of Gustaf Rasin as its new Chief Operations Officer (COO). Gustaf Rasin will play a vital role in refining the company's operational workflows and fostering its growth and environmental sustainability vision.

Where do the majority of your temperature excursions occur? Why not eliminate them?

TSS, a leading temperature monitoring solutions provider, is pleased to announce the appointment of Thomas Lindén as its new Chief Technology Officer (CTO). In this role, Thomas Lindén will play a crucial part in shaping the company's technological landscape and driving its growth strategies.

In light of the recent EMA and FDA guidelines, this session will discuss what role temperature monitoring may play in decentralized (DCT) and direct-to-patient (DTP) studies.

According to Lie Berglind, Chief Quality Officer at TSS, quality management is the soul of every organization. It is about doing what we say we should do, but also about measuring and determining how it was done, as well as documenting it to discover opportunities for improvement.

Loggers with reusable components can decrease the carbon footprint by almost 90% compared to disposable. These important discoveries were made during a close collaboration between business, research, and authorities to prepare for more environmentally and socially sustainable business practices.

Customer onboarding is one of the most important steps in making sure your customers are happy and confident in using your product. At TSS, we help companies in life sciences monitor complex temperature budgets with our advanced automated cloud software and temperature loggers. Making the onboarding process smooth is key to long-term customer satisfaction.

TSS, a leading provider of temperature-monitoring solutions for the life-science industry, proudly announces that it has retained the EcoVadis Silver Medal for the second consecutive year. This recognition is a testament to TSS’s ongoing commitment to sustainability, even as EcoVadis raised the bar for its assessment criteria in 2024.

Pharmaceutical companies are under pressure to bring new drugs to market quickly. This urgency is driven by the needs of patients, requirements from authorities, and investors. Clinical trials are a crucial part of this process, but they can be delayed by manual processes.

In the complex world of pharmaceuticals, sustainability is becoming a key part of business strategy. The push for a greener future is driven not only by government rules but also by the expectations of communities and customers. However, making the supply chain sustainable while balancing costs and maintaining high quality can be challenging. This requires careful planning and a commitment to long-term goals.

In the life-science industry, finding the right balance between cost and quality in the supply chain is crucial. This balance ensures that pharma companies remain financially healthy while delivering safe and effective products to patients. However, achieving this balance can be challenging due to the complexities of quality management, procurement, and temperature control.

World Telecommunication & Information Society Day (WTISD), celebrated annually on May 17th, highlights the pivotal role of digital technologies in fostering societal progress. This day serves as a reminder of the transformative power of innovation and digitalisation in building a sustainable future. At TSS, we are dedicated to leveraging advanced technologies to enhance the pharmaceutical supply chain while promoting sustainability.

Pharmaceutical companies are under pressure to bring new drugs to market quickly. This urgency is driven by the needs of patients, requirements from authorities, and investors. Clinical trials are a crucial part of this process, but they can be delayed by manual processes.

In the pharmaceutical industry, maintaining precise temperature control is paramount to ensuring product quality and compliance with regulatory standards. The integrity of pharmaceutical products is heavily reliant on storage conditions, with deviations in temperature potentially compromising their efficacy and safety.

Are you in pursuit of optimizing the temperature management of your clinical trials supply chain? Get inspired by experts from the field, and learn from their experiences.

The TSS User Forum is a platform for thought leadership and innovation in supply chain and temperature control technologies. This forum gathered industry experts from some of the most respected life science companies worldwide, covering topical realities such as automation benefits, data management, supply chain sustainability, and Direct-To-Patient.

Where do the majority of your temperature excursions occur? Why not eliminate them?

In an era where people can make instant cash transfers electronically from their phone and order physical goods to be delivered in hours to their location, there is a portion of the Clinical Supply Chain that seems mired in a staff intensive, manual, reactive business process. That process is evaluating temperature excursions for Clinical Trial material.

We believe automation is essential to making supply chains more visible and removing inefficiencies that come with manual tasks. Watch our webinar to find out more about how to achieve automation in your clinical supply chain.

Are healthcare professionals working at clinical sites across the world satisfied? It might seem like a strange question to ask, but the way we feel can impact our professional performance in important ways. Perhaps the question is not how satisfied Clinical Operations professionals are, but whether they feel their performance is impacted by lots of time-consuming manual processes that could benefit from automation? Are these processes hampering clinical trial performance?

Data is an essential requirement for improving supply chain processes. But that doesn’t mean that simply collecting more of it will instantly lead to reductions in waste, increases in efficiency and lower excursion rates. Taking a more targeted approach will help you turn supply chain data into insights that can help you understand exactly what is happening at every stage of your pharmaceutical supply chain.

The life science industry is always looking for ways to improve reliability and efficiency across the supply chain. New technologies for tracking and temperature logging hold great potential, but which to choose?

TSS introduces a new era of efficiency, with next-generation Bluetooth Low Energy temperature monitoring solutions that help life science supply chain professionals automate their processes for time and cost savings while securing patient safety.

Get introduced to the solution tailored to GxP critical shipments – BLE technology for temperature monitoring

The Future of Temperature Monitoring: How to lower the CO2 footprint with a Circular Supply Solution

Are you in pursuit of optimizing the temperature management of your clinical trials supply chain? Get inspired by experts from the field, and learn from their experiences.

Where do the majority of your temperature excursions occur? Why not eliminate them?

In light of the recent EMA and FDA guidelines, this session will discuss what role temperature monitoring may play in decentralized (DCT) and direct-to-patient (DTP) studies.

Where do the majority of your temperature excursions occur? Why not eliminate them?

We are excited to join the 20th Anniversary edition of Clinical Trial Supply East Coast on the 19th and 20th October 2022 in the Sheraton King of Prussia. The conference covers all things CTS from reducing timelines and streamlining processes to handling clinical supplies in a decentralized trial world. Along speakers from Pfizer, Merck, Janssen and many more we will present how digitalization of temperature processes can improve business outcomes in clinical trials.

New technologies for tracking and temperature logging hold great potential, but which to choose? Get a copy of our latest white paper.

Temperature management is critical when it comes to ensuring patient safety in clinical development, but we continue to use legacy point solutions that require heavy manual processes and duplication of data.